TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pierre Fabre Pharma Norden AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
210,803
|
229,774
|
202,658 |
Financial expenses |
349
|
550
|
278 |
Earnings before taxes |
6,442
|
7,620
|
5,655 |
EBITDA |
6,157
|
8,378
|
6,020 |
Total assets |
158,809
|
123,264
|
141,689 |
Current assets |
157,890
|
122,386
|
140,667 |
Current liabilities |
134,307
|
99,371
|
122,524 |
Equity capital |
24,502
|
23,893
|
19,165 |
- share capital |
405
|
378
|
390 |
Employees (average) |
16
|
15
|
14 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
15.4%
|
19.4%
|
13.5% |
Turnover per employee |
13,175
|
15,318
|
14,476 |
Profit as a percentage of turnover |
3.1%
|
3.3%
|
2.8% |
Return on assets (ROA) |
4.3%
|
6.6%
|
4.2% |
Current ratio |
117.6%
|
123.2%
|
114.8% |
Return on equity (ROE) |
26.3%
|
31.9%
|
29.5% |
Change turnover |
-35,276
|
33,207
|
20,202 |
Change turnover % |
-14%
|
17%
|
11% |
Chg. No. of employees |
1
![]() |
1
![]() |
1 |
Chg. No. of employees % |
7%
![]() |
7%
|
8% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.